Surgical management of Parkinson's disease: Update and review

Interventional Neuroradiology

Volumn 13, Issue 4, 2007, Pages 359-368

  Chao, Yu ^a   Gang, L ^a   Na, Z L ^b   Ming, W Y ^b   Zhong, W S ^b   Mian, W S ^c  

^a TIANJIN UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Huanhu Hospital   (China)

Author keywords

Ablative surgery; Cell transplantation; Deep brain stimulation; Gene therapy; Internal globus pallidus; Parkinson's disease; Subthalamus; Thalamus

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; LEVODOPA; PLACEBO;

BRAIN DEPTH STIMULATION; CLINICAL TRIAL; GENE THERAPY; GLOBUS PALLIDUS; HUMAN; NERVE CELL; NEUROPHYSIOLOGY; NEUROSURGERY; PALLIDOTOMY; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; SUBTHALAMIC NUCLEUS; SURGICAL APPROACH; SURGICAL TECHNIQUE; THALAMOTOMY; THALAMUS VENTRAL NUCLEUS; XENOTRANSPLANTATION;

EID: 39749115543     PISSN: 11239344     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101990701300407     Document Type: Review

References (117)

1. Fabbrini G, Juncos J et Al: Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease. Ann Neurol 21: 370-376, 1987.
2. Ahlskog JE, Muentex MD: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16: 448-458, 2001.
3. Lang AE, Lozano AM: Parkinson's disease. First of two parts. N Engl J Med 339: 1044-1053, 1998.
4. Lang AE, Lozano AM: Parkinson's disease. Second of two parts. N Engl J Med 339: 1130-1143, 1998.
5. Guridi J, Lozano AM: A brief history of pallidotomy. Neurosurgery 41: 1169-1183, 1997.
6. Speelman JD, Bosch DA: Resurgence of functional neurosurgery for Parkinson's disease: a historical perspective. Mov Disord 13: 582-588, 1998.
7. Laitinen LV, Bergenheim AT, Hariz MI: Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 76: 53-61, 1992.
8. Obeso JA, Rodriguez MC, DeLong MR: Basal ganglia pathophysiology. A critical review. Adv Neurol 74: 3-18, 1997.
9. Obeso JA, Guridi J, DeLong M: Surgery for Parkinson's disease. J. Neurol Neurosurg Psychiatry 62: 2-8, 1997.
10. Cosgrove GR, Eskandar E: Thalamotomy and pallidotomy. http://neurosurgery.mgh.harvard.edu/pallidt.htm Accessed: January 22, 2001.
11. Kelly PJ, Ahlskog JE et Al: Computer-assisted stereotactic Ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease. Mayo Clin Proc 62: 655-664, 1987.
12. Narabayashi H, Yokochi F, Nakajima Y. Levodopa induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatry 47: 831-839, 1984.
13. Selby G: Stereotactic surgery for the relief of Parkinson's disease, 1: a critical review. J Neurol Sci 5: 315-342, 1967.
14. Speelman JD: Parkinson's disease and stereotaxic surgery. Amsterdam: Elsevier Science Publishers, 1991.
15. Matsumoto K, Asano T et Al: Long-term follow-up results of bilateral thalamotomy for parkinsonism. Appl Neurophysiol 39: 257-260, 1976.
16. Baron MS, Vitek JL et Al: Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 40: 355-366, 1996.
17. Dogali M, Fazzini E et Al: Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 45: 753-761, 1995.
18. Fazzini E, Dogali M et Al: Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy. Neurology 48: 1273-1277, 1997.
19. Kishore A, Turnbull IM et Al: Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease. Six-month follow-up with additional 1-year observations. Brain 120: 729-737, 1997.
20. Lang AE, Lozano AM et Al: Posteroventral medial pallidotomy in advanced Parkinson's disease. N. Engl. J Med 337: 1036-1042, 1997.
21. Lozano AM, Lang AE et Al: Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 346: 1383-1387, 1995.
22. Ondo WG, Jankovic J et Al: Assessment of motor function after stereotactic pallidotomy. Neurology 50: 266-270, 1998.
23. Samuel M, Caputo E et Al: A study of medial pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications. Brain 121: 59-75, 1998.
24. Shannon KM, Penn RD et Al: Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at six months in 26 patients. Neurology 50: 434-438, 1998.
25. Uitti RJ, Wharen RE Jr et Al: Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Neurology 49: 1072-1077, 1997.
26. Fahn S, Epstein RL: Unified Parkinson's Disease Rating Scale Development Committee. Unified Parkinson's Disease Rating Scale. In Recent Developments in Parkinson's Disease, ed. S Fahn, CD Marsden, M Goldstein, p 153-164. Florham Park, NJ: Macmillan 1987.
27. Kumar R, Lozano AM et Al: Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 13: 73-82(Sup), 1998.
28. Starr PA, Vitek JL, Bakay: Ablative surgery and deep brain stimulation for Parkinson's Disease. Neurosurgery 43: 989-1015, 1998.
29. Louw D, Burchiel KJ: Complications of ablative therapy for movement disorders. Neurosurg Clin N Am 9: 367-373, 1998.
30. Biousse V, Newman NJ et Al: Visual fields in patients with posterior GPi pallidotomy. Neurology 50: 258-265, 1998.
31. Svennilson E, Torvik A et Al: Treatment of Parkinsonism by stereotactic thermolesions in the pallidal region. Acta Psychiatr Neurol Scand 35: 358-377, 1960.
32. Trepanier LL, Saint-Cyr JA et Al: Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 51: 207-215, 1998.
33. Scott R, Gregory R et Al: Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. Brain 121: 659-675, 1998.
34. Masterson D, DeSalles A, et Al: Motor, cognitive, and behavioral performance following unilateral ventroposterior pallidotomy for Parkinson's disease. Arch Neurol 55: 1201-1208, 1998.
35. Iacono RP, Shima F et Al: The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 36: 1118-1127, 1995.
36. Shima F, Ishido K et Al: Surgical control of akinesia in Parkinson's disease. Eur Neurol 36: 55-61, 1996.
37. Schuurman PR, deBie RMA et Al: Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients. Mov Disord 12: 752-755, 1997.
38. Roberts JW, Heilbrun MP: Staged bilateral ventroposterolateral pallidotomy for Parkinson's disease. Neurology 48: A358, 1997.
39. Ghika J, Villemure J-G et Al: Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2 year follow-up. J Neurosurg 89: 713-718, 1998.
40. Tasker RR, Lang AE et Al: Pallidal and thalamic surgery for Parkinson's disease. Exp Neurol 144: 35-40, 1997.
41. Alvarez L, Macias R et Al: Dorsal subthalamotomy for Parkinson's disease. Mov Disord 16: 72-78, 2001.
42. Su PC, Tseng HM, Liu HM et Al: Treatment of advanced Parkinson's disease by subthalamotomy: one-year results. Mov Disord 18: 531-538, 2003.
43. Patel NK, Heywood P et Al: Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain 126: 1136-1145, 2003.
44. Alvarez L, Macias R et Al: Bilateral dorsal subthalamotomy in Parkinson's disease (PD): initial response and evolution after two years. Mov Disord 17 (sup 5): S95, 2002.
45. Vilela Filho O, da Silva DJ: Unilateral subthalamic nucleus lesioning: a safe and effective treatment for Parkinson's disease. Arq Neuropsiquiatr 60: 935-948, 2002.
46. Ohye H, Narabayshi H: Physiological study of presumed ventralis intermedius neurons in the human thalamus. J Neurosurg 50: 290, 1979.
47. Bechtereva NP, Bondartchuk AN et Al: Method of electrostimulation of the deep brain structures in treatment of some chronic diseases. Conf Neurol 37: 136, 1975.
48. Mazars G, Merienne L, Cioloca C: Control of dyskinesias due to sensory deafferentation by means of thalamic stimulation. Acta Neurochirurg Suppl 30: 239, 1980.
49. Benabid AL, Pollak P et Al: Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337: 403, 1991.
50. Blond S, Caparros-Lefebvre D et Al: Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurgery 77: 62, 1992.
51. Benabid AL, Pollak P et Al: Combined(thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl Neurophysiol 50: 344, 1987.
52. Benabid AL, Pollock P et Al: Chronic electrical stimulation of the ventralis intermedius nucleus of thalamus as a treatment of movement disorders. J Neurosurgery 84: 203-214, 1996.
53. Koller W, Pahwa R et Al: High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42: 292-299, 1997.
54. Schuurman PR, Bosch A et Al: A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342: 461-468, 2002.
55. Wester K, Hauglie-Hanssen E: Stereotaxic thalamotomy - experiences from the levodopa era. J Neurol Neurosurg Psychiatry 53: 427-430, 1990.
56. Matsumoto K, Shichijo F, Fukami T: Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy. J Neurosurg 60: 1033-1044, 1984.
57. The Deep-Brain Stimulation for Parkinson's Disease Study Group: Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 345: 956-963, 2001.
58. Burchiel KJ, Anderson VC et Al: Comparison of pallidal and subthalamic nucleus deepbrain stimulation for advanced Parkinson's disease:results of a randomized, blinded pilot study. Neurosurgery 45: 1375-1382, 1999.
59. Volkmann J, Allert N et Al: Long-term results of bilateral pallidal stimulation in Parkinson's disease. Ann Neurol 55: 871-875, 2004.
60. Krack P, Pollak P et Al: Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 121: 451-457, 1998.
61. Scotto di Luzio AE, Ammannati F et Al: Which target for DBS in Parkinson's disease? Subthalamic nucleus versus globus pallidus internus. Neurol Sci 22: 87-88, 2001.
62. Volkmann J, Allert N et Al: Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology 56: 548-551, 2001.
63. Volkmann J, Sturm V et Al: Bilateral high frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 44: 953-961, 1998.
64. Kumar R, Lang AE et Al: Deep brain stimulation of the globus pallidus pars interna in advanced Parkinson's disease. Neurology 55 (sup 6): S34-39, 2000.
65. Durif F, Lemaire JJ et Al: Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson's disease. Mov Disord 17: 803-807, 2002.
66. Loher TJ, Burgunder JM et Al: Long-term pallidal deep brain stimulation in patients with advanced Parkinson disease: 1-year follow-up study. J Neurosurg 96: 844-853, 2002.
67. Krack P, Pollak P, Limousin P et Al: Opposite motor effects of pallidal stimulation in Parkinson's disease. Ann Neurol 43: 180-192, 1998.
68. Loher TJ, Burgunder JM et Al: Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 73: 395-399, 2002.
69. Sugiyama K, Yokoyama T, Namba H: Neurosurgical treatment for dopamine-induced dyskinesias in Parkinson's disease patients. Nippon Rinsho 58: 2115-2119, 2000.
70. Gross C, Rougier A et Al: High-frequency stimulation of the globus pallidus; internalis in Parkinson's disease: a study of seven cases. J Neurosurg 87: 491-498, 1997.
71. Nutt JG, Rufener SL et Al: Interactions between deep brain stimulation and levodopa in Parkinson's disease. Neurology 57: 1835-1842, 2001.
72. Katayama Y. Deep brain stimulation (DBS) therapy for parkinson,s disease. Nippon Rinsho 58: 2078-2083, 2000.
73. Defebvre LJ, Krystkowiak P et Al: Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease. Mov Disord 17: 76-83, 2002.
74. Krystkowiak P, Blatt JL et Al: Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system. J Neurol 248: 944-949, 2001.
75. Pahwa R, Wilkinson S et Al: High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease. Neurology 49: 249-253, 1997.
76. Miyawaki E, Perlmutter JS et Al: The behavioral complications of pallidal stimulation: a case report. Brain Cogn 42: 417-434, 2000.
77. Dujardin K, Krystkowiak P et Al: A case of severe dysexecutive syndrome consecutive to chronic bilateral pallidal stimulation. Neuropsychologia 38: 1305-1315, 2000.
78. Troster AI, Fields JA, Wilkinson SB et Al: Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology 49: 1078-1083, 1997.
79. Vingerhoets G, van der Linden C et Al: Cognitive outcome after unilateral pallidal stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry 66: 297-304, 1999.
80. Krack P, Batir A et Al: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 349: 1925-1934, 2003.
81. Limousin P, Krack P et Al: Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339: 1105-1111, 1998.
82. Brown RG, Dowsey PL et Al: Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol 45: 473-488, 1999.
83. Vingerhoets FJ, Villemure JG et Al: Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 58: 396-401, 2002.
84. Benabid AL, Benazzouz A et Al: Dyskinesias and the subthalamic nucleus. Ann Neurol 47 (4 sup 1): S189-192, 2000.
85. Albanese A, Nordera GP, Caraceni T, Moro E: Long-term ventralis intermedius thalamic stimulation for parkinsonian tremor. Adv Neurol 80: 631-634, 1999.
86. Saint-Cyr JA, Trepanier LL: Neuropsychologic assessment of patients for movement disorder surgery. Mov Disord 15: 771-783, 2000.
87. Hariz MI, Johansson F et Al: Bilateral subthalamic nucleus stimulation in a parkinsonian patient with pre-operative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov Disord 15: 136-139, 2000.
88. Ardouin C, Pillon B et Al: Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46: 217-223, 1999.
89. Thobois S, Mertens P, Guenot M et Al: Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients. J Neurol 249: 529-534, 2002.
90. Bejjani BP, Damier P et Al: Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 340: 1476-1480, 1999.
91. Dujardin K, Defebvre L et Al: Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. J Neurol 248: 603-611, 2001.
92. Kulisevsky J, Berthier ML et Al: Mania following deep brain stimulation for Parkinson's disease. Neurology 59: 1421-1424, 2002.
93. Berney A, Vingerhoets F et Al: Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 59: 1427-1429, 2002.
94. Krack P, Fraix V et Al: Postoperative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord 17 (sup 3): S188-197, 2002.
95. Kumar R, Krack P, Pollak P: Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 341: 1003-1004, 1999.
96. Krack P, Kumar R, Ardouin C et Al: Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord 16: 867-875, 2001.
97. Freed CR, Greene PE et Al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344: 710-719, 2001.
98. Hagell P, Piccini P et Al: Dyskinesias following neural-transplantation in Parkinson's disease. Nat Neurosci 5: 627-628, 2002.
99. Ma Y, Feigin A, Dhawan V et Al: Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 52: 628-634, 2002.
100. Mendez I, Dagher A et Al: Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. J Neurosurg 96: 589-596, 2002.
101. Barker RA: Porcine neural xenografts: what are the issues? Novartis Found Symp 231, 184-196, 2000.
102. Barker RA, Kendall AL, Widner H: Neural tissue xenotransplantation: what is needed prior to clinical trials in Parkinson's disease? Neural Tissue Xenografting Project. Cell Transplant 9, 235-246, 2000.
103. Schumacher JM et Al: Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54, 1042-1050, 2000.
104. Deacon T et Al: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 3, 350-353, 1997.
105. Hauser RA, Watts R, Freeman TB: A double-blind, randomised, controlled, multicenter clinical trial of the safety and efficacy of transplanted fetal porcine ventral mesencephalic cells versus imitation surgery in patients with Parkinson's disease. Mov Disord 16, 3-4, 2001.
106. Arenas E: Stem cells in the treatment of Parkinson's disease. Brain Res Bull 57: 795-808, 2002.
107. Kim SU, Lee MA et Al: Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. Neurosci Lett 333: 74-78, 2002.
108. Kim JH, Auerbach JM et Al: Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418: 50-56, 2002.
109. Yang M, Stull ND et Al: Neural stem cells spontaneously express dopaminergic traits after transplantation into the intact or 6-hydroxydopaminelesioned rat. Exp Neurol 177: 50-60, 2002.
110. Bjorklund LM, Sanchez-Pernaute R, Chung S et Al: Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349, 2002.
111. Ostenfeld T, Tai YT et Al: Neurospheres modified to produce glial cell fine-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res 69: 955-965, 2002.
112. Akerud P, Canals JM et Al: Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinsons disease. J Neurosci 21: 8108-8118, 2001.
113. Akerud P, Holm PC et Al: Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinsons disease. Mol Cell Neurosci 21: 205-222, 2002.
114. Gill SS, Patel NK, Hotton GR et Al: Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9: 589-595, 2003.
115. Nutt JG, Burchiel KJ et Al: Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60: 69-73, 2003.
116. Kordower JH, Emborg ME et Al: Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. 290: 767-73, 2000.
117. During MJ, Kaplitt MG et Al: Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 12: 1589-1591, 2001.